CA
16
3
YUM
43
5
UHS
58
2
CMI
59
14
AON
49
2
MSFT
46
2
ISRG
71
2
KMB
34
6
KHC
20
2
KSS
42
4
CME
56
3
PNC
55
3
IR
61
6
PFG
36
3
MS
69
3
PEG
50
4
ETN
69
2
LEN
53
3
BRK.B
27
2
AIV
51
4
CA
16
3
YUM
43
5
UHS
58
2
CMI
59
14
AON
49
2
MSFT
46
2
ISRG
71
2
KMB
34
6
KHC
20
2
KSS
42
4
CME
56
3
PNC
55
3
IR
61
6
PFG
36
3
MS
69
3
PEG
50
4
ETN
69
2
LEN
53
3
BRK.B
27
2
AIV
51
4
Financhill
Back

Structure Therapeutics Vs. Novo Nordisk AS Industry Stock Comparison

Sell
36

GPCR
Structure Therapeutics

Last Price:
39.29
Seasonality Move:
-35.87%
Sell
36

NVO
Novo Nordisk AS

Last Price:
110.04
Seasonality Move:
7.98%
Sell
36
Structure Therapeutics (GPCR) is a Sell

Is Structure Therapeutics a Buy, Sell or Hold?

  • The current Structure Therapeutics [GPCR] share price is $39.30. The Score for GPCR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • GPCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $110.13. The Score for NVO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GPCR Stock Price Chart

What is Structure Therapeutics's stock price today?

  • The Structure Therapeutics share price today is $39.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing slight selling pressure.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $110.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 49.78 Sell
Chaikin Money Flow: -61027 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.61 - 41.39) Sell
Bollinger Bands (100): (36.19 - 42.83) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.43 Sell
Relative Strength Index (14 RSI): 28.5 Sell
Chaikin Money Flow: 5524545 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (112.57 - 118.31) Sell
Bollinger Bands (100): (119.81 - 140.01) Sell

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.15 Buy
20-day SMA: 38.81 Buy
50-day SMA: 39.59 Sell
200-day SMA: 40.27 Sell
8-day EMA: 39.42 Sell
20-day EMA: 39.31 Sell
50-day EMA: 39.42 Sell
200-day EMA: 39.72 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.84 Sell
20-day SMA: 115.18 Sell
50-day SMA: 123.49 Sell
200-day SMA: 128.24 Sell
8-day EMA: 111.96 Sell
20-day EMA: 114.98 Sell
50-day EMA: 121.01 Sell
200-day EMA: 122.69 Sell

Structure Therapeutics Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.07 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.87 per share.

Structure Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):